View this email in your browser

   ESC General Assembly 2018

Paid-up members for 2018 will be welcome to attend the General Assembly (GA) which will take place on Thursday, 10 May 2018 from 17:15 - 18:15.
Place of the meeting: HungExpo, Albertirsai ut 10, 1101 Budapest, Hungary.
The agenda of the General Assembly can be found in the members only part:
Standard reports will be posted on the website in the coming days for your information. These items will not be covered during the GA. Looking forward to meeting you all in Budapest,
Medard Lech, Secretary General

   Contraception Atlas 2018

The European Parliamentary Forum on Population & Development (EPF) launched the Contraception Atlas 2018. In this second edition, the Atlas tracks government policies on access to contraceptives, counselling, and provision of online information, in 46 European states. Belgium, France and the United Kingdom rank best of the 46 countries surveyed.
More information

  Apply now for an ESC Grant

This grant may be used to support an individual, group, institute or organisation with a project that has a scientific basis with described, relevant outcome(s) and is related to the aims of the ESC. A maximum of 10,000 euro per project application can be requested.


The ESC will provide funding to support a regional or local educational course or meeting within Europe related to the aims of the ESC. A maximum of 5,000 euro per course application can be requested.
More information

   BZgA new releases

  • Training matters: A new framework on the competencies of sexuality educators
  • Policy Brief No. 3 ‘Introducing Sexuality Education: Key Steps for Advocates in Europe and Central Asia’
  • Policy Brief No. 4 ‘Why Should Sexuality Education be Delivered in School-based Settings?’
More information

   Exelgyn/FIAPAC Grant 2018, “Improving the quality of life for women having a medical abortion”

Exelgyn, in partnership with FIAPAC, will provide funding to support an individual, group, institute or organisation with a project within Europe related to the aims and scope of the Exelgyn/FIAPAC project "Improving the quality of life for women having a medical abortion". Conditions & application form.

  • Who can apply? Paid-up FIAPAC members.
  • Deadline applications: 31 May 2018.
  • Project applications should be sent to:
  • Budget: 10 000 euros maximum for the successful application.
  • Questions?
More information

   Updated measures for pregnancy prevention during retinoid use

The European Medicines Agency (EMA) has completed its review of retinoid medicines, and confirmed that an update of measures for pregnancy prevention is needed. In addition, a warning on the possibility that neuropsychiatric disorders (such as depression, anxiety and mood changes) may occur will be included in the prescribing information for oral retinoids (those taken by mouth).

The review confirmed that oral retinoids can harm the unborn child and must not be used during pregnancy. In addition, the oral retinoids acitretin, alitretinoin and isotretinoin, which are used to treat conditions mainly affecting the skin, must be used in accordance with the conditions of a new pregnancy prevention programme by women able to have children.

The press release is available by clicking here and includes information to patients and healthcare professionals.

More information

   Journal highlight

Johannes Bitzer (Editor-in-Chief) his highlight from volume 23, 2018 the issue 1 of the European Journal of Contraception and Reproductive Health Care:
Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use

This article is temporary open acces.

ESC Events

Copyright © 2018 *European Society of Contraception and Reproductive Health*, All rights reserved

Contact: Tel. +32 2 582 08 52/

Want to change how you receive these emails?
You can unsubscribe from this list.